Ajax-Loading

Novartis AG - Total Other Income Expense Net

Novartis AG's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Total-Other-Income-Expense-Net" stands at -0.9695 Billion United States Dollars for the trailing twelve months (TTM) period ending 06/30/2026.

Novartis AG's second quarter result of -0.4549 Billion USD for the item "Total Other Income Expense Net" represents a decrease of -574.53 percent compared to it's first quarter result.

Also, Novartis AG's second quarter result of -0.4549 Billion USD for the item "Total Other Income Expense Net" represents a decrease of -36.60 percent compared to it's second quarter result of last year.

Looking again at the trailing twelve months series (TTM), Novartis AG's second quarter result of -0.9695 Billion USD for the item "Total Other Income Expense Net" represents a decrease of -14.38 percent compared to it's first quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 0.1065 Billion United States Dollars compared to the value the year prior.
The 1 year change is 0.1065 Billion United States Dollars.
The 3 year change is -0.2915 Billion United States Dollars.
The 5 year change is -0.9445 Billion United States Dollars.
The 10 year change is -0.2795 Billion United States Dollars.

The Serie's long term average value is 1.14 Billion United States Dollars. It's latest available value, on 06/30/2026, is -2.11 Billion United States Dollars lower, compared to it's long term average value.
The Serie's change in United States Dollars from it's minimum value, on 12/31/2025, to it's latest available value, on 06/30/2026, is +0.23 Billion.
The Serie's change in United States Dollars from it's maximum value, on 12/31/2021, to it's latest available value, on 06/30/2026, is -15.42 Billion.

Total Other Income Expense Net for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Total Other Income Expense Net905,699,262,464.00
LogoJohnson & Johnson - Total Other Income Expense Net486,508,953,600.00
LogoAbbVie Inc - Total Other Income Expense Net399,570,305,024.00
LogoRoche Holding AG - Total Other Income Expense Net317,433,206,677.55
LogoAstraZeneca PLC - Total Other Income Expense Net280,205,508,085.11